Structural and functional properties of prefibrillar α-synuclein oligomers - Test2 - elhamkhani - TriplyDB

Structural and functional properties of prefibrillar α-synuclein oligomers

Structural and functional properties of prefibrillar α-synuclein oligomers

http://www.wikidata.org/entity/Q36796130

about

Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins.Alpha-synuclein prevents the formation of spherical mitochondria and apoptosis under oxidative stress Pre-aggregation kinetics and intermediates of α-synuclein monitored by the ESIPT probe 7MFE.Alpha-synuclein oligomers: a new hope.Alpha-synuclein, proteotoxicity and Parkinson's disease: Search for neuroprotective therapy.Structural features of α-synuclein amyloid fibrils revealed by Raman spectroscopy.Does Parkinson's disease start in the gut?Physical Chemistry in Biomedical Research: From Cuvettes toward Cellular Insights.Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson's Disease in Rodents.Taurine protects dopaminergic neurons in a mouse Parkinson's disease model through inhibition of microglial M1 polarization.Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson's Disease: An In Situ Proximity Ligation Assay Study.2D polarization imaging as a low-cost fluorescence method to detect α-synuclein aggregation ex vivo in models of Parkinson's disease

P2860

Q38773604-03BF0E9C-A285-4C0B-9E1C-68AB59DCD985 Q42320467-F874FDED-273C-4245-86A1-7D6B21AF313B Q46236939-2EEC47F5-205B-4E98-9EB9-AF10EFAC39E7 Q46321755-A9671B83-C79F-4676-AD0E-BAF81549F92C Q47348189-B7FA22B4-6E8B-45D7-BC58-3300C5719701 Q47388669-71208635-79DF-4D60-BD33-1F13D05CB20D Q47893450-75F3F800-9AC3-4DE2-B031-1811A06D5A23 Q48198177-8963C0C2-C36A-45AE-A393-C26E7362EB81 Q50199812-D5A3BCF8-2133-4916-87CC-A68A00073B2F Q52641738-6291550A-F160-4897-AC5D-DDFCA8EBBB35 Q55715226-7CCA2EE2-F6B3-4608-B332-BB66256CD406 Q57298268-136F2CA5-72F5-4EAD-9A6F-FB917376B31A

P2860

Structural and functional properties of prefibrillar α-synuclein oligomers

http://www.wikidata.org/entity/Q36796130

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Structural and functional properties of prefibrillar α-synuclein oligomers

@en

type

label

Structural and functional properties of prefibrillar α-synuclein oligomers

@en

prefLabel

Structural and functional properties of prefibrillar α-synuclein oligomers

@en

P1433

Q36796130-1BCB2A92-93F9-496D-9343-7C6B7862EDA2

P1476

Q36796130-01FF06B4-004F-4D27-ACF0-939D13BCF1D0

P2093

Q36796130-63B8E2F3-1F97-44D9-8406-AECD704BB123

Q36796130-C311A9FC-F849-4F1D-8050-7FC411EE6E5E

Q36796130-EA3C6410-763A-4C1A-BF9D-9E539408F0ED

P2860

Q36796130-01E087F9-0DF5-4941-93C4-6E9207BC9FD1

Q36796130-06E4397B-FE51-4874-9197-3A860C6E0A41

Q36796130-07CC2E5D-1C36-4BCE-861B-22435798F372

Q36796130-0B28EDB0-6AC0-461C-A0F8-BA23A89E8249

Q36796130-0CCE083A-D9CC-4E67-92C8-3E80B3BEA2E0

Q36796130-19A1E4CF-D8F5-4104-9E19-04B02CF7E2F5

Q36796130-1DE10D37-9DE1-4C76-B8C4-B5E4982B03A4

Q36796130-1E0EAFE8-C197-4D53-8F99-8C75695798BA

Q36796130-24830AE5-3EE1-4D73-BF03-4C26AA192592

Q36796130-28C87E96-8CDB-4819-8E9C-3C37CB368BD4

P2888

Q36796130-BE5BBECA-0332-403B-ADA3-980D3EF550EA

P304

Q36796130-04676DDC-081B-4AE4-A751-9F950018E02A

P31

Q36796130-92D5B80E-339C-4C89-BF7F-8DA97C597245

P356

Q36796130-BF48CC24-195A-49BB-A75E-BE6D41D605E9

P407

Q36796130-D215C131-96C4-4136-8CCD-2A38FACE9DA8

P478

Q36796130-0F45F6D1-4058-4EA7-8C39-A7C7DD82480E

P577

Q36796130-796BBF8A-1C96-4D39-9730-6619CBC0385F

P5875

Q36796130-24A293C9-8697-4FFA-974A-48BB78680513

P698

Q36796130-74B05678-B763-417A-A7F9-410FCA5F5A9F

P921

Q36796130-07B30AA1-CBED-4F63-9469-7D800679C179

P932

Q36796130-572F7552-B41B-484B-809D-663499F86738

P356

P1433

Scientific Reports

P1476

Structural and functional properties of prefibrillar α-synuclein oligomers

@en

P2093

Karine Madiona

http://www.w3.org/2001/XMLSchema#string

Laura Pieri

http://www.w3.org/2001/XMLSchema#string

Ronald Melki

http://www.w3.org/2001/XMLSchema#string

P2860

Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models

α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells.

Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

Size-Distribution Analysis of Macromolecules by Sedimentation Velocity Ultracentrifugation and Lamm Equation Modeling

Spreading of pathology in neurodegenerative diseases: a focus on human studies

Staging of brain pathology related to sporadic Parkinson's disease

Size-distribution analysis of proteins by analytical ultracentrifugation: strategies and application to model systems

Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders

Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice

P2888

P304

24526

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP24526

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

301314922

http://www.w3.org/2001/XMLSchema#string

P698

27075649

http://www.w3.org/2001/XMLSchema#string

P921

P932

4830946

http://www.w3.org/2001/XMLSchema#string